TORONTO, ON / ACCESSWIRE / June 6, 2023 / Sparta Group (TSXV:SAY) (OTC PINK:SCAXF) (the "Corporation", the "Company", "Sparta Group", "Sparta Capital", "SAY.V" or "Sparta), has just announced the addition of Dr. Craig Backs, an esteemed Internal Medicine Specialist with a focus on Heart Attack and Stroke prevention to its Technical Advisory Board ("TAB").
A graduate of Southern Illinois University School of Medicine, and former Chief Medical Officer at St. John's Hospital in Springfield, Illinois, Dr. Backs is an experienced and respected Specialist. He focuses on disease prevention with a style that is much like your local football coach. Backs believes in and practices guiding each player (patient) to execute his or her own individualized "CurePlan" so they can reverse, or even cure many chronic diseases.
Backs is currently CEO/CMO of CureCoach Inc., and has established The Cure Centre for Chronic Disease to help prevent heart attack, stroke, and Type 2 Diabetes, using knowledge gained from training in the Bale/Doneen Method. His CureCoach App is now available to millions of people around the globe who suffer from chronic conditions.
Dr. Backs and Sparta management share the same point of view when it comes to modern healthcare. They see a future where people are going to be seeking alternatives to conventional medicine and where technology, especially those that can be delivered via smart phone or tablet, will assist healthcare professionals, as well as patients in ways we never imagined possible before.
"As the newest member of Sparta's TAB, my hope is to have our development team work closely with Sparta's Achu Health™ and Doctor-in-a-Box ™ teams to integrate our Cure Coach platform to theirs. Our goal is to motivate seemingly healthy people to avoid diseases of hyperinsulinemia; in-turn reducing heart disease and many cancers. By combining these platforms, I feel we have a real opportunity to raise awareness about the ravaging effects insulin resistance can have on the human body," Dr. Backs stated.
Dr. Backs' appointment marks a significant milestone in the expansion of Sparta's Innovation division and the establishment of Sparta Health Corp.
"Doctor Backs ability to evaluate and implement the latest in advanced medical technology, along with his extensive medical background, make him a valuable addition to Sparta's TAB, especially as the company's newly formed Sparta Health Corp takes an active role in helping protect human health beyond viral outbreaks, including developing its own distinctive health solutions," stated John O'Bireck, President and CTO of Sparta Group.
Doctor Backs joins the 10 other distinguished professionals that sit on Sparta's Technical Advisory Board. The Board is made up of experts in finance, business management, energy, biology, physiology, computer technology, data-base development, engineering, scientific field research, as well as medical technology development.
About Sparta™
Sparta Group is leading a green revolution in the business world with advanced technologies that reduce carbon footprint, save money, and enhance public image. Our products solve problems by leveraging Web 3 technologies such as artificial intelligence, blockchain and machine learning to fast-track the transition towards a sustainable future.
With Sparta, businesses can optimize their energy usage, upcycle electronic waste and accelerate health technologies such as autonomous medicine. Our symbiotically structured divisions - Environment, Innovation and Energy - enable us to deliver customized solutions that fit the specific needs of each client.
We take pride in being the first North American company to provide verified high-quality carbon credits to our customers through electronic waste processing. Our state-of-the-art facilities in Toronto, Canada, and Oman (Arabian Peninsula) ensure that we are at the forefront of reducing the impact of e-waste on our environment.
Join the movement towards a more sustainable future with Sparta Group, where advanced technology meets eco-consciousness.
Sparta is a publicly traded company listed on the TSX Venture Exchange under the ticker symbol "SAY" (TSX.V: SAY) and (OTC: SCAXF). Additional information is available at www.spartagroup.ca or on SEDAR at www.sedar.com.
For further information please contact:
John O'Bireck, President
Email: jobireck@spartagroup.ca
Telephone: (905) 751-8004
Cautionary Statements:
This news release contains "forward-looking information" within the meaning of applicable securities laws. When used in this news release, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although the Corporation believes in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate that the expectations reflected in this forward-looking information are reasonable, readers are cautioned to not place undue reliance on forward-looking information because the Corporation can give no assurance that they will prove to be correct. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date of publication of this news release and the Corporation undertakes no obligation to update such forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Furthermore, the Corporation undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Corporation. In particular, this news release contains forward-looking statements relating to, among other things, statements pertaining to the "Offering" and actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the failure to obtain necessary regulatory approvals, necessary financing and risks associated with the environmental technologies industry in general. All forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Sparta Group
View source version on accesswire.com:
https://www.accesswire.com/759386/Sparta-Group-Strengthens-Technical-Advisory-Board-with-Appointment-of-Internal-Medicine-Specialist-Craig-Backs-MD-as-it-Advances-Health-Technologies
© 2024 Canjex Publishing Ltd. All rights reserved.